BioCurie, Co-Founder & CEO Irene Rombel, and Lithero, Co-Founder & CEO Nyron Burke | LIVE Episode | Founding Philly Ep. 38

In this episode, I had the privilege of interviewing Irene Rombel, Co-Founder and CEO of BioCurie, and Nyron Burke, Co-Founder and CEO of Lithero. Recorded live on 3/28 at Venture Cafe in front of an audience, we explored their companies' innovative use of AI in the Life Sciences sector.

Our conversation covered the challenges presented by the legal and regulatory landscape, and the substantial benefits AI offers for patient outcomes and efficiency within the life sciences industry. The discussion underscored the transformative potential of AI, from enhancing drug development and manufacturing processes to ensuring compliance and facilitating commercialization.

BioCurie is at the forefront of empowering biopharmaceutical companies to develop and manufacture lifesaving therapies more efficiently. Leveraging AI, they simulate process development and manufacturing, employing data-driven algorithms to conduct millions of simulations. 

This approach aims to optimize conditions from the outset, eliminating the costly and time-consuming trial-and-error method.

Lithero is a software company creating AI tools specifically for Pharma marketers and agencies. They focus on the commercial aspects of the life sciences process, introducing a product named LARA — an "artificial lawyer" that scrutinizes drug advertisements for potential compliance issues, alerting customers to any findings. 

This service is invaluable, ensuring that the public receives accurate content and understands the risks and benefits of pharmaceutical products, while the pharma companies don't spend hours on extensive manual review.

Tune into episode 38 of the Founding Philly podcast to hear Irene and Nyron share their personal journeys, delve into the opportunities and pitfalls of AI in Life Sciences, and explore how it has the potential to dramatically improve patient outcomes.

--

This episode is sponsored by EisnerAmper.